Supplementary Data from Clinical Acquired Resistance to KRAS&lt;sup&gt;G12C&lt;/sup&gt; Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK Reactivation